First-line Immuno-chemotherapy for extensive-stage small-cell lung cancer: A network meta-analysis and cost-effectiveness analysis.

Zhu, Youwen; Liu, Kun; Yang, Qiuping; Zeng, Manting; Peng, Libo

Zhu, Youwen; Liu, Kun; Yang, Qiuping; Zeng, Manting; Peng, Libo.

Afiliación

Zhu Y; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Liu K; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Yang Q; Department of Pathology, Tangshan Cancer Hospital, Tangshan, Hebei, China.
Zeng M; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Peng L; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.

Front Public Health ; 11: 1028202, 2023.

Article en En | MEDLINE | ID: mdl-37006537

Asunto(s)

Análisis de Costo-Efectividad; Neoplasias Pulmonares; Humanos; Metaanálisis en Red; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico; Análisis Costo-Beneficio; Neoplasias Pulmonares/tratamiento farmacológico

Palabras clave

cost-effectiveness; extensive-stage small-cell lung cancer; immuno-chemotherapy; network meta-analysis; quality-adjusted life-years

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Análisis de Costo-Efectividad / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Health_economic_evaluation / Systematic_reviews Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Front Public Health Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google